ES2191973T3 - Composiciones farmaceuticas para la administracion oral de yodo molecular. - Google Patents

Composiciones farmaceuticas para la administracion oral de yodo molecular.

Info

Publication number
ES2191973T3
ES2191973T3 ES98954002T ES98954002T ES2191973T3 ES 2191973 T3 ES2191973 T3 ES 2191973T3 ES 98954002 T ES98954002 T ES 98954002T ES 98954002 T ES98954002 T ES 98954002T ES 2191973 T3 ES2191973 T3 ES 2191973T3
Authority
ES
Spain
Prior art keywords
iodine
molecular iodine
pharmaceutical compositions
oral administration
stomach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98954002T
Other languages
English (en)
Spanish (es)
Inventor
Yongjun Duan
John Hickey
Rick Panicucci
Jack Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symbollon Corp
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Application granted granted Critical
Publication of ES2191973T3 publication Critical patent/ES2191973T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES98954002T 1997-10-29 1998-10-27 Composiciones farmaceuticas para la administracion oral de yodo molecular. Expired - Lifetime ES2191973T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine

Publications (1)

Publication Number Publication Date
ES2191973T3 true ES2191973T3 (es) 2003-09-16

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98954002T Expired - Lifetime ES2191973T3 (es) 1997-10-29 1998-10-27 Composiciones farmaceuticas para la administracion oral de yodo molecular.

Country Status (17)

Country Link
US (1) US5885592A (enExample)
EP (1) EP1024815B1 (enExample)
JP (1) JP4187410B2 (enExample)
KR (1) KR100412219B1 (enExample)
CN (1) CN1150904C (enExample)
AT (1) ATE231725T1 (enExample)
AU (1) AU750627B2 (enExample)
BR (1) BR9812588A (enExample)
CA (1) CA2301503C (enExample)
DE (1) DE69811105T2 (enExample)
DK (1) DK1024815T3 (enExample)
ES (1) ES2191973T3 (enExample)
IL (1) IL134778A0 (enExample)
NO (1) NO20001673L (enExample)
PT (1) PT1024815E (enExample)
RU (1) RU2213564C2 (enExample)
WO (1) WO1999021567A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
AU1693099A (en) * 1998-01-06 1999-07-26 Fujisawa Pharmaceutical Co., Ltd. Solid preparation of iodophor and its manufacturing methods
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
ATE320831T1 (de) * 2000-10-06 2006-04-15 Dmg Italia Srl Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
JP4586018B2 (ja) * 2003-06-20 2010-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 猫における甲状腺機能亢進症を予防する方法及び限定されたヨウ素を含む組成物
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
RU2432941C2 (ru) * 2006-01-26 2011-11-10 Хилл'С Пет Ньютришн, Инк. Способы и композиции для лечения гипертиреоза у кошачьих
AU2007249806B2 (en) * 2006-05-12 2011-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CN101511205A (zh) * 2006-07-03 2009-08-19 希尔氏宠物营养品公司 用于在甲状腺机能亢进的猫科动物中预防或治疗心血管疾病的组合物和方法
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
KR20140033123A (ko) * 2011-05-16 2014-03-17 쇼칸 사비르하노비치 베갈리예프 항바이러스성, 항궤양 및 면역 자극 작용을 가지고, 르네상스라는 이름을 가지는 의학 조제물
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
WO2015153258A1 (en) 2014-03-31 2015-10-08 Iotech International, Llc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
AU2017300497A1 (en) 2016-07-21 2019-03-14 I2Pure Corp. Emollient topical disinfectants
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
BR112023001995A2 (pt) 2020-08-13 2023-02-28 I2Pure Corp Composições de alta concentração de iodo molecular, formulações farmacêuticas, preparação e usos
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
IL134778A0 (en) 2001-04-30
AU750627B2 (en) 2002-07-25
PT1024815E (pt) 2003-06-30
EP1024815B1 (en) 2003-01-29
AU1122799A (en) 1999-05-17
DE69811105D1 (de) 2003-03-06
CA2301503A1 (en) 1999-05-06
RU2213564C2 (ru) 2003-10-10
DK1024815T3 (da) 2003-05-19
NO20001673L (no) 2000-05-24
ATE231725T1 (de) 2003-02-15
JP2003510243A (ja) 2003-03-18
KR20010030861A (ko) 2001-04-16
WO1999021567A1 (en) 1999-05-06
JP4187410B2 (ja) 2008-11-26
EP1024815A1 (en) 2000-08-09
CA2301503C (en) 2005-01-04
KR100412219B1 (ko) 2003-12-24
NO20001673D0 (no) 2000-03-31
BR9812588A (pt) 2000-07-25
CN1150904C (zh) 2004-05-26
CN1272789A (zh) 2000-11-08
DE69811105T2 (de) 2003-11-06
US5885592A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
ES2191973T3 (es) Composiciones farmaceuticas para la administracion oral de yodo molecular.
GR900100786A (el) Μέ?οδος παρασκευής μιας συν?έσεως η οποία να περιλαμβάνει ένα αναλγητικό με συνδιασμό με ένα παρεμποδιστή του Η1 ή Η2 ένα παρεμποδιστή αντλίας πρωτονίων ή ένα συνδυασμό αυτών.
EA199700266A1 (ru) Фармацевтическая композиция, содержащая выбранные гидраты карбоната лантана
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DK0736004T3 (da) (2,4-disulfophenyl)-N-t-butylnitron, salte heraf og deres anvendelse som indfangningsmidler til farmaceutiske radikaler
AR012995A1 (es) Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de medicamentos y composiciones farmaceuticas que contienedichos compuestos.
CO4940409A1 (es) Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior
AR018732A1 (es) Iminoazucares alquilados para prevenir, reducir o revertir la resistencia a la multidroga en el tratamiento quimioterapeutico y composicionfarmaceutica que los contiene.
ES2149979T3 (es) Composicion estabilizada para la administracion oral de peptidos.
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
AR012417A1 (es) COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION.
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
IT1255723B (it) Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
CO4230093A1 (es) Derivados del indol y sus usos medicos
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
ES2150404T1 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
IL70407A (en) Synergistic analgesic pharmaceutical compositions in unit dosage form,comprising an analgesic agent and hydroxyzine
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
DK1462107T3 (da) Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde
AR029415A1 (es) Pirroles sustituidos, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos
CO5580790A2 (es) Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs
IT1265342B1 (it) Composizioni farmaceutiche a base di derivati della glicina
AR010343A1 (es) Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica.
EA199700025A1 (ru) Применение олигосахарида и аспирина для приготовления медикаментов, предназначенных для лечения тромбоэмболических заболеваний, фармацевтическая композиция, способ лечения